CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
END2AMR addresses the global challenge of antimicrobial resistance by developing innovative antibacterial treatments and delivery methods. The project focuses on creating new therapies specifically targeting drug-resistant bacterial infections, particularly in low- and middle-income countries.
Antimicrobial-resistant and persistent bacterial infections represent major global healthcare challenges, imposing substantial costs and highlighting the urgent need for new and more effective treatment options.
The World Health Organization and other international bodies have identified critical gaps in the current antibacterial drug discovery pipeline, which relies heavily on similar mechanisms of action and fails to address the needs of low- and middle-income countries.
The rapid emergence of…
STICHTING LYGATURE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Dundee
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Tres Cantos
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Belgium, Kampenhout
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Denmark, Kobenhavn
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
